The therapeutic potential of the pharmacological inhibition of PBEF/NAMPT/Visfatin in inflammatory bowel disease

被引：0
|
作者：
Gerner, R. [1 ]
Wieser, V. [1 ]
Bichler, A. [1 ]
Moschen, A. [1 ]
Tilg, H. [1 ]
机构：
[1] Univ Innsbruck, Dept Internal Med 1, A-6020 Innsbruck, Austria
来源：
JOURNAL OF CROHNS & COLITIS | 2014年 / 8卷
关键词：
D O I：
10.1016/S1873-9946(14)60130-6
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P006
引用
收藏
页码：S67 / S67
页数：1
相关论文
共 50 条
  • [1] Visfatin/PBEF/Nampt and Other Adipocytokines in Inflammatory Bowel Disease
    Neubauer, Katarzyna
    Krzystek-Korpacka, Malgorzata
    ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2010, 19 (03): : 399 - 404
  • [2] No inflammation without energy: Inhibition of PBEF/NAMPT/Visfatin as a potential new treatment strategy in inflammatory bowel diseases
    Gerner, R. R.
    Macheiner, S.
    Wieser, V.
    Pfister, A.
    Moschen, A. R.
    Tilg, H.
    TOXICOLOGY LETTERS, 2016, 258 : S136 - S136
  • [3] INHIBITION OF NAMPT (PBEF/VISFATIN) DECREASES THE ABILITY OF HUMAN NEUTROPHILS TO GENERATE REACTIVE OXIDANTS, BUT DOES NOT IMPAIR BACTERIAL KILLING
    Roberts, Kate J.
    Moots, Robert J.
    Edwards, Steven W.
    RHEUMATOLOGY, 2012, 51 : 47 - 47
  • [4] Inflammatory bowel disease: Potential therapeutic strategies
    Nielsen, OH
    Vainer, B
    Bregenholt, S
    Claesson, MH
    Bishop, PD
    Kirman, I
    CYTOKINES CELLULAR & MOLECULAR THERAPY, 1997, 3 (04) : 267 - 281
  • [5] Bacteriotherapy for inflammatory bowel disease: therapeutic tool and/or pharmacological vectors?
    Marteau, P.
    Sokol, H.
    Dray, X.
    Seksik, P.
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2009, 33 : S228 - S234
  • [6] JAK Inhibition as a Therapeutic Strategy for Inflammatory Bowel Disease
    Macaluso, Fabio Salvatore
    Rodriguez-Lago, Iago
    CURRENT DRUG METABOLISM, 2020, 21 (04) : 247 - 255
  • [7] Pharmacological- and non-pharmacological therapeutic approaches in inflammatory bowel disease in adults
    Gerda C Leitner
    Harald Vogelsang
    World Journal of Gastrointestinal Pharmacology and Therapeutics, 2016, (01) : 5 - 20
  • [8] Is Cannabis of Potential Value as a Therapeutic for Inflammatory Bowel Disease?
    Timna Naftali
    Digestive Diseases and Sciences, 2019, 64 : 2696 - 2698
  • [9] Adrenomedullin as a Potential Therapeutic Agent for Inflammatory Bowel Disease
    Ashizuka, Shinya
    Inatsu, Haruhiko
    Inagaki-Ohara, Kyoko
    Kita, Toshihiro
    Kitamura, Kazuo
    CURRENT PROTEIN & PEPTIDE SCIENCE, 2013, 14 (04) : 246 - 255
  • [10] Therapeutic Potential of Amino Acids in Inflammatory Bowel Disease
    Liu, Yulan
    Wang, Xiuying
    Hu, Chien-An Andy
    NUTRIENTS, 2017, 9 (09):
12345